Myriad Genetics Announces Second Quarter Fiscal 2006 Financial Results Conference Call; Tuesday, February 7, 2006 at 10:00 a.m. ET

SALT LAKE CITY, January 31, 2005 – Myriad Genetics, Inc. (Nasdaq: MYGN) (www.myriad.com) has arranged a conference call with the management team to provide a company update. Peter Meldrum, President and Chief Executive Officer will host the call along with Jay Moyes, Chief Financial Officer, Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc. and Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

DATE: February 7, 2006
TIME: 10:00 am ET
DOMESTIC DIAL-IN: (888) 589-2820
INTERNATIONAL DIAL-IN: (706) 634-2173
CONFERENCE ID# 4574985
(Please dial in approximately 10 minutes before the call is scheduled to begin)

A press release will be issued at 6:30 am ET on February 7, 2006. Replay of the call will be available from two hours after the call through February 14th by dialing (800) 642-1687 or (706) 645-9291, and entering conference ID number 4574985.

A live audio Webcast will be available at: www.myriad.com

This call is being webcast by Thomson/CCBN and is also being distributed though the Thomson/StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com, Thomson/CCBN's individual investor portal. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).